Rep. Porter grills Big Pharma CEO for putting profits before patients
During a recent committee hearing, Congresswoman Katie Porter called out a Big Pharma CEO for spending 3 times as much on stock buybacks than lifesaving research—to the tune of $28,600,000,000.